Specific Use-result Surveillance of Spiriva respimat in asthmatics (patients with severe persistent asthma) (Specific Use-result Surveillance in asthmatics)

26/05/2015
15/12/2025
EU PAS number:
EUPAS9802
Study
Finalised
Documents
Study protocol
Initial protocol
English (112.57 KB - PDF) View document
Study results
Study results
English (219.28 KB - PDF) View document
Study report
Other information